MEDUSA
MEDUSA has been developed for healthcare, institutional, commercial and professional environments, combining proprietary formulation know-how with an asset-light route to market across direct supply, distribution, licensing and strategic partnerships.
Scientific differentiation · Recurring institutional demand · Multiple commercial channels
MEDUSA addresses the professional hygiene, infection-prevention and surface-disinfection market across healthcare, hospitality, commercial and institutional environments, with recurring purchasing and repeat-use characteristics.
Global surface-disinfectant market range
Estimated 2025 antimicrobial / long-residual surface technologies market
Estimated 2030 residual-protection market
Residual protection represents a faster-growing sub-category within the broader disinfection market.
Saudi Arabia · UAE · GCC · United Kingdom · Germany · France · United States
>5-LOG - Reported reduction against S. aureus and P. aeruginosa after five minutes under tested conditions.
>4-LOG - Reported reduction against C. albicans and Phi-6 after five minutes under tested conditions.
10 DAYS - Reported residual virucidal performance against Phi- 6 on a treated metal surface under the tested protocol.
ECOLAB
Institutional scale and recurring professional demand.
DETTOL / LYSOL
Global consumer recognition and established hygiene distribution.
3M / DIVERSEY
Validation that major incumbents are moving toward longer-duration and residual surface-protection technologies.
MEDUSA
Proprietary formulation know-how, residual-performance positioning, measurable verification and an asset-light commercial model.
The opportunity is not to replicate incumbent scale, but to commercialise differentiated science into a large and established category.
During 2023, MEDUSA was evaluated through a six-month research and development programme conducted across more than 300 operating environments in the UAE, including hospitals, schools, hotels and selected aviation, hospitality and logistics settings. The programme examined residual surface performance under practical use conditions using quaternary-ammonium / DDAC test-strip verification as part of the measurement framework.
Baseline readings taken before MEDUSA application generally indicated 0–5% residual-active readings. Following application, tested surfaces recorded an average reading of approximately 72% across the programme, providing a measurable real-world dataset supporting the platform’s residual-performance proposition.
300+
Operating environments assessed
6 MONTHS
UAE field-testing programme
~72%
Average post-application residual reading across tested surfaces
Hospitals · Schools · Hospitality · Aviation · Logistics · Commercial environments
Selected research environments
Representative organisations associated with environments included within the wider research and development programme. Supporting test records and related materials are available for diligence upon request.
Logos are shown solely to identify representative research environments and do not imply endorsement, partnership or current commercial relationship. Testing outcomes relate to the specific methodologies, conditions, surfaces and measurement protocols used during the programme.